Europace

Article	Citations
Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?	603
Examination of pituitary adenylate cyclase-activating polypeptide (PACAP) in patients with atrial fibrillation undergoing pulmonary vein isolation	399
Impact of pulsed-field ablation on kidney function	293
The effect of virtual reality on anxiety reduction in supraventricular tachycardia ablation: prospective study	278
Early detection of fluid retention with a multisensory algorithm in chronic heart failure patients	231
Single-chamber versus dual-chamber pacing: real world data from the German national VIDEO project	215
Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial	209
Pulmonary vein isolation with the novel radiofrequency balloon catheter: predictors of single-shot isolation	164
Coronary sinus cannulation as real time anatomical landmark to facilitate left bundle branch area pacing	149
A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: acute results from the Micra AV post-approval registry	142
Serial arterial blood gas monitoring during deep sedation for left atrial ablation procedures: a retrospective cohort study	138
CRT with triple fusion: results of the multicentric, randomized, doble-blinded CRUSTY trial	124
CIED replacement optimization: feasibility, safety and acceptability of day surgery setting for CIED replacement	116
Extended use of preprocedural data to detect expiratory airflow limitation in patients with atrial fibrillation scheduled for ablation	116
Pulsed field ablation of the left common pulmonary vein: a new single-shot solution?	111
New insights from repeated extra-cardiac vagal nerve stimulation after recent successful cardioneuroablation in high risk patients with vagally-mediated bradyarrhythmias	110
Analysis of mitral isthmus ablation in patients undergoing a second ablation procedure after atrial fibrillation ablation with electroporation vs. radiofrequency	110
New onset, recurrence and progression of atrial fibrillation after cardiac surgery during 2.5 years of continuous rhythm monitoring	108
The new "olive strategy" for pulsed field ablation of atrial fibrillation: procedural data and early follow-up	105
Volumetric quantification of epicardial fat using semiautomated atrial CT segmentation in patients with atrial fibrillation: the Prospective AFAT study	103
High efficacy and safety of endocardial pulsed electrical field ablation via contact force-controlled catheters for mitral isthmus ablation	94
Implementation of near zero fluoroscopy in supraventricular tachycardia ablation procedures: a single center experience	94
Computed tomography as a predictive tool for ventricular tachycardia	85
Adherence to a mobile health-based atrial fibrillation screening program: a subanalysis from STROKESTOP I and II	82
Rhythm matters: sinus and pace rhythm map significantly differ in endo/epicardial 3D electroanatomic mapping	80

Prevalence and risk factors of pre-procedural left atrial thrombus in patients undergoing pulmonary vein isolation	78
Ablation for idiopathic ventricular arrhythmias using focal pulsed field ablation	76
Sudden cardiac death and atrial depolarization in coronary artery disease—Authors’ reply	74
Preclinical evaluation of safety and efficacy of the Coherent Sine-Burst Electroporation (CSE) ablation system in a chronic porcine beating heart model	72
Management of modifiable risk factors and comorbidities in atrial fibrillation: suggestions for improvement from a patient perspective	71
Long-term effects of catheter ablation versus antiarrhythmic drugs on health-related quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial revisited	71
LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial	69
Early vs. delayed vt ablation in patients with ischemic cardiomyopathy	68
Atrioventricular nodal reentrant tachycardia ablation (avnrt), a female disease. insights from the german ablation registry	66
Left atrial low-voltage areas, but not volume, predict the recurrence of atrial fibrillation in repeat ablation procedures	65
Cardiac magnetic resonance - aided ventricular tachycardia substrate ablation	65
Clinical validation of an artificial intelligence algorithm offering automated corrected QT-interval measurements from a single lead electrocardiogram	65
Stiff but keeping the beat: catheter ablation for atrial fibrillation in cardiac amyloidosis and sarcoidosis	63
Artificial intelligence assisted QT interval measurement in 12-lead-ECGs	63
First experience of focal pulsed field ablation for premature ventricular contractions	63
Hemolysis after atrial fibrillation ablation conducted with a new point-by-point pulsed field ablation device	62
Different approaches to atrial fibrillation ablation in heart failure patients: temporal trends and clinical outcomes	62
Optimisation of decrementing evoked potential mapping for functional substrate identification in ischaemic ventricular tachycardia ablation	61
Scar architecture determinants of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study	61
Pacemaker dependency after Cox Maze procedure concomitant with cardiac surgery, The road between Scylla and Charybdis	60
MicroPort CRM considerations on Vega pacing lead performance	59
Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion	58
Conduction system pacing vs biventricular pacing in patients with left bundle branch block and resynchronization therapy indication. CONSYST-CRT trial secondary findings	56
Ventricular pre-excitation in young patients: long term follow-up and natural history in a contemporary cohort	56
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation	56
Genetic and clinical risk factors for stroke recurrence with different impact by assessment age: data from the UK Biobank	55
Impact of additional pulsed field ablation in unsuccessful radiofrequency linear lesions -acute and chronic data	54
Long-term heart failure improvement after catheter ablation of persistent atrial fibrillation in heart failure with preserved, mildly reduced and reduced ejection fraction	54
Left atrial epicardial adipose tissue: correlation to left atrial fibrosis and arrhythmia recurrence post atrial fibrillation ablation	54
Identification of a real-world clinical model associated with atrial fibrillation in a large french primary care database	53
Does the rhythm have an additional effect - left atrial strain measurement in heart failure patients with HFrEF and in patients with atrial fibrillation and preserved ejection fraction	52
Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis	51
Ultra-high density mapping and ablation of localized microreentrant tachycardias: insight from the CHARISMA registry	51
A Bayesian meta-analysis on recurrence of atrial arrhythmia between Hybrid AF ablation and endocardial AF ablation	51
Pulsed field ablation of persistent and long-standing persistent atrial fibrillation: acute safety, efficacy and long-term outcome from a nationwide experience	50
The predictive ability of the QT response in supine-standing test for drug induced QT prolongation	50
Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke	50
Left-sided slow pathway ablation for atrioventricular nodal reentrant tachycardia: a single center experience	50
Simplification of resetting response in slow/fast atrioventricular nodal reentrant tachycardia: the 3 catheters approach	50
The link between ischaemic stroke, ischaemic heart disease, and atrial fibrillation	50
Different predictors of AF recurrence after pulmonary vein isolation with cryoballoon and radiofrequency ablation: insights from clinical and electroanatomical mapping data of the NO-PERSAF study	49
Imaging-derived tissue visualization guides catheter ablation of premature ventricular contractions	49
Magnetic resonance imaging in patients with cardiac implantable electronic devices: the RESONANCE Spanish registry	48
Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators	48
Electrographic flow mapping of persistent atrial fibrillation: intra- and inter-procedure reproducibility in the absence of ‘ground truth’	48
Jailed or freed? The lead dilemma in transcatheter tricuspid valve replacement	47
The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study	47
Atrial cardiomyopathy delays the endothelialization process of left atrial appendage occluders	47
Novel four-exon deletion in ryanodine receptor gene (RYR2) associated with mixed electric and structural cardiac phenotype	46
Permanent epicardial pacing : a first line strategy in children	46

Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study	46
Initial heart rate score predicts new-onset atrial tachyarrhythmias in pacemaker patients	45
Prevalence and characteristics of arrhythmias during the pregnancy	44
Evaluation of posterior mitral isthmus ablation in the absence of a vein of Marshall	43
Correction to: Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology	42
Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation	42
Extraction of lumenless pacing leads from the His bundle and left bundle branch area: outcomes of the high-volume centre	42
Cardioneuroablation for treatment of atrioventricular block: to cure the patient or the electrocardiogram?	42
Manual compression versus modified figure-of-8 stitch after left atrial ablations: a comparative randomized trial	42
Cardiac magnetic resonance to evaluate 3D ventricular substrate depth: Prognostic implications for VT ablation approach	41
Innovative approaches to atrial fibrillation prediction: should polygenic scores and machine learning be implemented in clinical practice?	41
Clinical impact of capsulectomy during cardiac implantable electronic device generator replacement: a prospective randomized trial	41
Public procurement of cardiac implantable electronic devices across Europe: are we purchasing value or cost-effectiveness?	41
Hybrid atrial fibrillation ablation: long-term outcomes from a single-centre 10-year experience	41
LAT velocity vectors: a novel tool for ventricular functional substrate characterization	40
Reduction in long-term mortality using remote device monitoring in a large real-world population of patients with implantable defibrillators	40
Distribution of peri-device leaks on transoesophageal echocardiography and cardiac computed tomography after WATCHMAN implantation: a multicentre core-lab analysis	39
Correction to: Accuracy of non-invasive electrocardiographic imaging in scar-dependent ventricular tachycardia: relationship to arrhythmogenic substrate and imaging defined scar	39
Optical mapping and optogenetics in cardiac electrophysiology research and therapy: a state-of-the-art review	38
Underlying reasons for sex difference in survival following out-of-hospital cardiac arrest: a mediation analysis	38
Carbon footprint of atrial fibrillation catheter ablation	38
Virtual pacing of a patient’s digital twin to predict left ventricular reverse remodelling after cardiac resynchronization therapy	38
Left-atrial function in relation to BMI in patients undergoing catheter ablation for atrial fibrillation	37
Incidence of pulmonary vein stenosis following atrial fibrillation ablation with standard-power long-duration, high-power and very high-power short-duration, and pulsed-field ablation	37
Sex differences in metabolic and inflammatory profiles in arrhythmogenic cardiomyopathy: insights from myocardial and plasma omics	36
Optimizing pace-and-ablate: structural determinants of transmural lesion formation in atrial ablation	36
Paced QRS duration during right ventricular pacing using a pseudo-surface electrocardiogram recorded by a pacemaker programmer	36
Coaxial electrograms demonstrate directional independence and enhanced far-field rejection, as well as accurate activation determination in fibrotic substrates	36
Temporal dynamics of atrial fibrillation follow power-laws: evidence for self-organised criticality	36
Atrial fibrillation reporting with semaglutide versus tirzepatide in eudravigilance: a comparative disproportionality analysis	35
Cerebrovascular ischemic lesions after pulsed field ablation for atrial fibrillation using variable-loop ablation catheter	35
Validity and reliability of an smartwatch single-lead ECG for monitoring QT interval prolongation: an interventional study with moxifloxacin	35
Atrial arrhythmia recurrence in hypertrophic cardiomyopathy: insights from repeat ablation	35
Therapeutic strategies and long-term follow-up in patients presenting with left atrial thrombus despite oral anticoagulation	35
Utility of a novel non-steerable 3 French decapolar catheter for mapping of distal coronary sinus during ablation of premature ventricular contractions originating from the left ventricular summit	34
Cardioneuroablation in hypervagotonic bradyarrhythmias: physiological endpoints and outcomes in a retrospective single-centre cohort	34
One procedure or two? Comparing concomitant and staged leadless pacemaker strategies after device infection (LEXIS subanalysis)	33
Electrical and mechanical impacts of left posterior, anterior and proksimal fascicular trunk capture during left bundle branch area pacing: a single center observational study	33
Bi-atrial synthetic populations with geometry-conditioned conduction velocity for atrial fibrillation simulations	33
Non-invasive Predictors of recurrence after catheter ablation for idiopathic PVCs	33
Impact of pulsed field ablation on outcome in obese patients undergoing pulmonary vein isolation for atrial fibrillation	33
Leadless pacemakers in patients with active haematological cancer: procedural details and long-term clinical outcomes	32
Properties during implant and the presence of transitions to confirm capture of Bachmann's Bundle	32
Pulsed-field ablation using a penta-spline catheter in pulmonar vein isolation. Comparative analysis of general anaesthesia and deep sedation	32
Comparison of baseline characteristics of population in france LEADLESS Registry and first ventricular leadless pacemaker implants in US	32
Real-world outcomes of a combined ablation strategy in patients with atrial fibrillation: Spatio-temporal dispersion-based personalised catheter ablation associated with vein of Marshall ethanol infus	32
Acute e chronic feasibility of left atrial appendage isolation focal ablation catheter toggling between radiofrequency and pulsed field energy	32
Safety and efficacy of the use of intravenous flecainide in the context of an aggressive rhythm control strategy in patients with atrial fibrillation in the emergency department (HEROMEDICUS study)	32
Single-shot ablation for AF: real-world procedural and one-year outcomes with the newly adopted PulseSelect PFA compared with cryoballoon from the 1STOP project	32
Transvenous lead extraction: Experience of the Tandem approach	31
Distinct atrial remodeling in valvular heart disease: insights from strain imaging and electrophysiological mapping	31
The Wolff–Parkinson–White pattern in neonates: results from a large population-based cohort study	31
Occurrence and long-term outcomes of pacing-induced cardiomyopathy in a large leadless pacemaker cohort	31
Impact of pulsed field ablation on urinary tubular markers in patients with atrial fibrillation: a comparison with radiofrequency ablation	31
Recurrence risk of atrial fibrillation in the 1-year post-ablation with radiofrequency in patients with high p wave dispersion and low voltage areas	31
State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), an	30
Promoting differentiation of human-induced pluripotent stem cells into sinoatrial node-like cells through programmed regulation of AMPK signalling pathway	30
Comparison of readmission outcomes and complications between leadless and traditional transvenous pacemakers in older adults: a nationwide readmission analysis of 49852 admission events	30
Timing of stroke risk reassessment in atrial fibrillation patients with a CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study	30
Impact of atrial fibrillation diagnosis-to-ablation time on 24-month efficacy and safety outcomes in the Cryo Global Registry	30
Electromechanical factors associated with favourable outcome in cardiac resynchronization therapy	30
Controversy: the blanking period after atrial fibrillation ablation is needed and should be maintained	30
Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study	29
Corrigendum to: Infanticide vs. inherited cardiac arrhythmias	29
Predicting dementia in patients with atrial fibrillation using machine learning of a large multimodal registry	29
Device-lead abnormalities and function after transcatheter tricuspid valve replacement	29
Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review	29
Electroanatomic mapping system guided His bundle pacemaker implantation: experience of the His bundle registry graz	29
Bipolar radiofrequency ablation of refractory ventricular arrhythmias: results from a multicentre network	29
Comparison of quality-of-life following cryoballoon versus radiofrequency catheter ablation of symptomatic atrial fibrillation - a subanalysis of the FREEZE cohort study	29
Volume-weighted unipolar voltage identifies diffuse fibrosis in patients with non-ischemic cardiomyopathy	28
Pulmonary vein isolation with additional substrate ablation for atrial fibrillation results in an increased risk for the development of atypical atrial flutter	28
Which paced QRS duration can be achieved in selective and non-selective His bundle pacing?	28
Evaluating the efficacy of pre-ablation algorithms in WPW syndrome localization: a retrospective study	28
Cardioversion strategy impacts quality of rate control during recurrences of atrial fibrillation	28
Usefulness of simultaneous isolation of the coronary sinus and the left atrial inferior wall for persistent atrial fibrillation refractory to box isolation	28
Impact of pulmonary vein anatomy and ostial dimensions on long term outcome after single-shot device guided cryoablation for paroxysmal atrial fibrillation	28
Long-term outcome after catheter ablation for fascicular ventricular tachycardia in a single high-volume center in Germany	28
Left-bundle branch block, an alert for cardiac resynchronization therapy	28
The impact of the catheter ablation on long-term prognosis in patients with hypertrophic cardiomyopathy and atrial fibrillation	28

Rigorous and long-term cardiac monitoring strategy in cryptogenic stroke or TIA patients in a tertiary care centre results in a two-fold increase in AF detection	28
Biatrial ablation versus left atrial ablation for atrial fibrillation treatment in patients with rheumatic heart disease undergoing valve surgery: a systematic review and meta-analysis	28
In memoriam: Stuart J. Connolly, MD, 9 April 1949–2 June 2024	28
Evidence for a shift from right ventricular to left ventricular outflow tract origin of idiopathic premature ventricular contractions with advancing age	27
Characterization and clinical significance of hemolysis after pulsed-field ablation for atrial fibrillation: insights from a multicentric analysis	27
Very-early detection of atrial fibrillation in patients after ablation evaluated by a home-based wearable ECG-patch	27
Electrophysiologic effects of left bundle branch area pacing: comparing left ventricular septal pacing and left bundle branch pacing	27
Weight change does not impact the long-term outcomes following pulmonary vein isolation in obese patients with atrial fibrillation	27
What determines who gets cardiac resynchronization therapy in europe?	27
Prognostic significance of beat-to-beat variability of spatial heterogeneity of repolarisation analysed from 5-minute resting electrocardiogram in coronary artery disease	27
Non-standard approach for device selection. Left bundle branch optimized ICD for patients with heart failure and LBBB	27
Optimized workflow with hybrid (very) high-power short-duration radiofrequency ablation renders point-by-point pulmonary vein isolation as fast and effective as cryoballoon ablation	27
Practicing physicians perception of feasibility and usefulness of quality indicators of treatment for atrial fibrillation	27
In-hospital mortality following catheter ablation procedures in Germany: insights from the VARY project	27
Increased pacemaker implantation and mortality rates in relatives of patients with early-onset sinus node dysfunction: can genetics explain all?	26
Impact on ganglionated plexi and arrhythmia recurrence of pulmonary vein isolation with pulsed field ablation compared to thermal energy	26
Optimal timing of of cardiac implantable electronic device reoperation	26
Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study	26
Association between amount of biventricular pacing and heart failure status measured by a multisensor implantable defibrillator algorithm	26
First-line Marshall plan approach in persistent atrial fibrillation: a prospective single-center cohort study	26
Weight-loss management after catheter ablation of atrial fibrillation	26
Renal denervation for the management of refractory ventricular arrhythmias	26
Non-invasive identification of deceleration zones in the atria using imageless ECGI: correlation with contact-mapping	26
Catheter ablation for the treatment of ventricular arrhythmias in the early phase following acute coronary syndrome	26
How to ablate the septo-pulmonary bundle: a case-based review of percutaneous ablation strategies to achieve roof line block	25
Heterogenous atrial conduction in patients with hypertrophic cardiomyopathy and atrial fibrillation	25
Anatomical and electrophysiological factors involved in atrial cardiomyopathy identify remodeling discrepancies between paroxysmal and persistent atrial fibrillation	25
Targeted left ventricular lead positioning to the site of latest activation in cardiac resynchronization therapy: a systematic review and meta-analysis	25
Association between regular exercise and the risk of major adverse cardiovascular events in patients with pacemaker	25
Outcomes of percutaneous left atrial appendage occlusion device implantation in atrial fibrillation patients based on underlying stroke risk	25
Identifying (electrophysiological) predictors of atrial fibrillation recurrences after catheter ablation: first results from the ISOLATION registry	25
360° Virtual reality to improve patient education and reduce anxiety towards atrial fibrillation ablation	25
Atrial fibrillation screening for stroke prevention: an instrumental variables meta-analysis addressing varying participation rates	25
Ventricular septal defect characteristics influence presence and properties of septal anatomical isthmuses in patients with repaired tetralogy of Fallot	25
Diagnostic accuracy of smartwatches for automated atrial fibrillation detection over time: insights from the basel wearable study	25
Implantable cardioverter-defibrillator implantation should be considered in high-risk patients with apical hypertrophic cardiomyopathy as the same manner with the septal type	25
AV synchrony maintained by a dual-chamber leadless pacemaker in real-world conditions	25
Acute procedural outcomes of left bundle branch area pacing compared to His-bundle pacing	24
Genetic testing in children with Brugada syndrome: results from a large prospective registry	24
Ablation of anomalous mitral annular pathways via transradial access: early hospital discharge due to the covid-19 pandemic	24
Novelty about pocket histology at cardiac implantable electronic device reopening procedures	24
Markers of atrial myopathy in the UK Biobank: prevalence, consequences, and risk stratification	24
High comorbidity burden is not associated with increased risk of periprocedural pericardial effusionduring left atrial ablation procedures: data from a large tertiary-care ablation center	24
AV block occurrence in normal AV conduction CRT fusion pacing: single center experience	24
Tackling of challenging accessory pathways utilizing open window mapping, does it add benefit?	24
The effect of thresholding techniques on 3D quantitative scar metrics in patients with implantable cardioverter defibrillator	24
Pinpointing atrial fibrillation drivers by informed sequential endocardial mapping in the presence and absence of fibrosis: an in-silico study	24
Vascular complications of pulsed-field ablation of atrial fibrillation using a streamlined procedural workflow - when less is not more	24
Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy—a nationwide cohort study	23
Current practice in the management of syncope in Italian hospitals: a national survey	23
Atrial fibrillation after patent foramen ovale closure in patients with embolic stroke of undetermined source	23
Atrial fibrillation and heart failure temporality: does it matter?	23
Selective sparing of Purkinje fibres with pulsed-field myocardial ablation	23
Deep septal pacing for pacemaker-induced cardiomyopathy	23
Cardiac implantable electronic devices following orthotopic heart transplantation: insights on indications and outcomes from a single centre experience	23
Renal outcomes of early rhythm control in patients with atrial fibrillation and chronic kidney disease	23
In silico biatrial fibrosis ablation improves atrial fibrillation outcome	23
Additional coils mitigate elevated defibrillation threshold in right-sided implantable cardioverter defibrillator generator placement: a simulation study	23
Early post-ablation rhythm monitoring using smartphone-based PPG: a real-world comparison of RFA and PFA	22
Differential effect of high-frequency electroporation on myocardium vs. non-myocardial tissues	22
Mapping and ablation outcomes of extra-pulmonary vein triggers in atrial fibrillation: single-centre retrospective study with consistent provocation protocol	22
Comparison of spatiotemporal dispersion electrogram ablation and low voltage zone ablation in patients with persistent atrial fibrillation	22
Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family	22
Impact of maintenance anaesthetics on total emissions of an atrial fibrillation catheter ablation procedure	22
Influence of dielectric perfusate on pulsed-field ablation-induced haemolysis	22
Validation of the PADIT risk score for predicting cardiac device-related pocket and systemic infections	22
Software-based analysis of T-wave morphology: identifying the electrocardiogram signature of high-risk long QT syndrome	22
Ganglionated plexi ablation impact on AF mechanisms and outcomes in patients with low scar burden	22
Non-invasive assessment of ventricular electrical uncoupling by electrocardiographic imaging as a predictor of biventricular pacing cardiac resynchronization therapy response	22
Electrocardiographic repolarization changes following conduction system pacing in pacemaker-induced cardiomyopathy	21
Prognosis of asymptomatic patients who underwent a sodium channel blocker challenge	21
In vivo trafficking and functional analysis of hERG missense variants in a CRISPR/Cas9-engineered C. elegans model of congenital long-QT syndrome	21
Performance of a cloud-based AI solution for reducing false positive alerts in implantable cardiac monitors detected episodes	21
Ethanol infusion to the vein of Marshall combined with anatomical and electrophysiological substrate modification improves long-term outcomes in very long-standing atrial fibrillation	21
Analysis of guideline-directed medical therapy in patients with reduced ejection fraction undergoing pulsed field ablation for atrial fibrillation: a multicentre study	21
Validation of an automated algorithm to consistently divide bi-atrial geometries from multiple imaging modalities according to the 15-segments bi-atrial model	21
Pulsed field ablation for premature ventricular contractions: a systematic review and meta- analysis of safety, acute and mid-term outcomes	21
Neuromodulation strategy implementation in a modern high-volume VT unit program	21
Obstructive sleep apnea assessment using a wearable medical device in patients post-catheter ablation for atrial fibrillation: Validation and predictive value	21
Electroanatomic visualization of coronary arteries: a case series to elicit safety, feasibility, and diagnostic value in complex ablation procedures	21
Postmortem interrogation of cardiac implantable electronic devices - results from a large prospective registry	21
Efficacy of complex signal identification-guided redo ablation for atrial fibrillation	21
TiFFANY micro: fatal adverse events after microelectrode radiofrequency AF ablation - an analysis of the FDA MAUDE database	21
Use of noninvasive electrocardiographic imaging to predict ablation success in persistent atrial fibrillation	21
Alcohol use disorder and clinical outcomes in atrial fibrillation: a nationwide cohort study	21
Quality of life and psychological distress in patients with implantable cardioverter-defibrillators: the PSY-ICD study	21
Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement	21
Progress in atrial fibrillation ablation during 25 years of Europace journal	21
Newly induced atrioventricular nodal reentrant tachycardia after catheter ablation for atrial fibrillation: association with proximal coronary sinus ablation	21
Ventricular pacing dynamics in patients with third degree atrioventricular block after TAVR in a real world single center experience	21
Assessment of left atrial hemodynamics and myopathy markers in patients undergoing repeat catheter ablation for atrial fibrillation	21
A morphology-based ECG algorithm for identifying left atrial fibrosis in atrial fibrillation	21
Impact of early catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction - real world evidence	20
A novel bioimpedance mapping system to assess ablation lesion quality and transmurality	20
Pulmonary vein isolation durability across energy modalities: redo insights from a high-volume center	20